Solaris Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Solaris Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,000	Closed	-$115K	–	231
2014 Q4	$115K	Hold	1,000	–	–	0.07%	115
2014 Q3	$156K	Hold	1,000	–	–	0.1%	102
2014 Q2	$123K	Hold	1,000	–	–	0.08%	105
2014 Q1	$104K	Hold	1,000	–	–	0.07%	109
2013 Q4	$90K	Hold	1,000	–	–	0.06%	133
2013 Q3	$67K	Hold	1,000	–	–	0.05%	150
2013 Q2	$66K	Buy	+1,000	New	+$57.2K	0.05%	154

Other funds holding SLXP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Solaris Asset Management's SLXP Position: Q1 2015 in Review

Solaris Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 1,000 shares — an estimated $115K sold.

Solaris Asset Management first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $156K in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Solaris Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Solaris Asset Management sold 1,000 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $115K.
Solaris Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Solaris Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $156K in Q3 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Solaris Asset Management's 13F filing for Q1 2015, filed 7 May 2015.